TY - JOUR
T1 - Using drugs safely in chronic kidney disease
AU - Kirby, M.
N1 - Original review can be found at: http://www.pccj.eu/ Copyright the journal [Full text of this review is not available in the UHRA]
PY - 2011
Y1 - 2011
N2 - Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.
AB - Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.
UR - http://www.scopus.com/inward/record.url?scp=80052935539&partnerID=8YFLogxK
U2 - 10.3132/pccj.2011.040
DO - 10.3132/pccj.2011.040
M3 - Book/Film/Article review
AN - SCOPUS:80052935539
SN - 1756-5138
VL - 4
SP - 17
EP - 20
JO - Primary Care Cardiovascular Journal
JF - Primary Care Cardiovascular Journal
IS - SPEC. ISSUE
ER -